You would have thought I-MED’s sell-side advisers have enough to occupy themselves with a $4 billion auction, but there’s an unwanted element to the process.
The Permira-owned radiology giant, which is up for sale via Morgan Stanley and Jefferies, has been the subject of articles from news website Crikey, kicking off with allegations last week that it had allowed VC-backed start-up Harrison.ai to use its patient scans to train artificial intelligence without consent.
Loading...
Sarah Thompson has co-edited Street Talk since 2009, specialising in private equity, investment banking, M&A and equity capital markets stories. Prior to that, she spent 10 years in London as a markets and M&A reporter at Bloomberg and Dow Jones. Email Sarah at sarah.thompson@afr.com
Emma Rapaport is a co-editor of the Street Talk column. Prior to that, she was a markets reporter at The Australian Financial Review. Connect with Emma on Twitter. Email Emma at emma.rapaport@afr.com
